Search

The pandemic of Covid-19 represents a chance to rethink the equilibrium of our territories and cities. The sudden revision of rules of social coexistence, the temporary suspension of activities, the modification of everyday gestures, physical public spaces replaced by digital spaces, are only some of the phenomena which happened simultaneously in 2020 due to the pandemic. From the will to reflect in a collective way on the implications of the health emergency on our ways of living, and from the project will to use the crisis as an experimentation field of new practices of sharing and elaboration of future urban scenarios, the campaign #MyCityofTomorrow of the spin-off Urban LIFE (University of Florence) was designed as an online platform of open dialogue on the topics which inform urban design and planning, in its broader sense, a discussion table to orient the restarts towards a more sustainable future.

Serum levels of amylase, pancreatic isoamylase, lipase, trypsinogen, and elastase 1 were determined in 41 patients with pancreatic carcinoma and compared with those 71 patients with chronic pancreatitis and 17 patients with digestive non-pancreatic carcinoma, in an attempt to evaluate their relative values in the diagnosis of pancreatic cancer. Trypsinogen and elastase 1 levels were the most frequently abnormal (56%), followed by pancreatic isoamylase (39%), lipase (34%), and amylase (27%). In 4 patients with resectable cancer levels of all serum enzymes were within normal limits, with the single exception of a low trypsinogen level in one patient. No significant differences in the behavior of serum enzymes were found between patients with pancreatic cancer and those with chronic pancreatitis or digestive non-pancreatic cancer. The results of our study indicate that measurement of serum pancreatic enzymes is of limited usefulness in the diagnosis of pancreatic cancer.